Articles related to VACCINES/IMMUNIZATION

The current real-world cohort study examines long-term survival outcomes in the 5 years after a COVID-19 hospitalization for adults with a solid malignancy. The study assessed the impact of vaccination status, vaccine platform, primary tumor site, and cancer treatment.

Investigators surmised that current influenza vaccination programs provide substantial protection but could be further improved by strategies that could mitigate repeat vaccination effects.

“ACP believes it is important for patients and clinicians to have robust vaccine recommendations based on science rather than politics.” — Goldman, Mitchell & Hopkins, Annals of Internal Medicine

The study highlights the importance of integrated preventive measures, especially for adults with traditional risk factors for CVD. Vaccines may play an important role in preventing the risk of CVD.

Genomic analyses revealed that all circulating strains were descendants of the Omicron JN.1 variant, “representing the first season without a SARS-CoV-2 strain replacement since the beginning of the COVID-19 pandemic.”

“ACOG’s withdrawal from ACIP is not a withdrawal from our commitment to advancing vaccine science or to protecting patients’ health and safety.” – ACOG President Steven J. Fleischman, MD